OPINION: Positive ID Corporation. Saturday, 03Jun2017
+
PSID, hired former government official (from the Obama administration)to work as a contractor. Presumably Dr. Smith's prior assignment(s) might facilitate, said corporations, effort to implement SenseNet. [end extract]
Given the original statement of work's stringent guidelines, failure to perform will result in a DHS recommendation to cancel all or part of the effort. There would not be any follow on proposal. Leaving PSID with only the very competitive public health sector in which to market products.
If collectively or in part the product(s) were viable, as described by PSID management, efforts to compensate / return shareholder equity would have resulted in the sale of the company.
Noting, as well, the U.S. government may deploy a prototype for testing; however, there must be a declaration, said product is compliant and fully operational. Further, no declaration presently exists outlining PSID's strategic relationship with any prime contractor. Neither has PSID disclosed whether their portion of the agreement was awarded as a "sole source" / "no-compete" option granting them specific remedies if SenseNet or Firefly was not accepted by the government, or Boeing, or any partner.
Circumstantially absent are references to any pending license agreement(s) supporting PSID's claim and intent to export said product for private or commercial use.
Department of Defense contracts have oversight; with said authority residing within OMB and congress; inclusively [U.S. Department of the Interior via DHS Science & Technology Directorate.]
Attempts to defraud entities, public or private, regardless the place of incorporation, carry a burden of proof, the company was not complicit in such activities.
+
May 30, 2017
PositiveID Subsidiary ExcitePCR Names Chief Science Officer
Dr. Kimothy Smith served as Senior Advisor for International Biodefense at Department of Homeland Security's Office of Health Affairs
DELRAY BEACH, Fla., May 30, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today its wholly owned subsidiary, ExcitePCR Corporation, has named Dr. Kimothy Smith its Chief Science Officer.
Dr. Smith, a recognized biodefense expert, will join Lyle Probst, the CEO of ExcitePCR, to manage the development of Firefly Dx to completion and commercialization, and execute the company's mission under the U.S. Department of Homeland Security ("DHS") SenseNet program to provide faster, less expensive bio-threat detection systems while providing an added level of security.
Dr. Smith served as Senior Advisor for International Biodefense at DHS' Office of Health Affairs and as Acting Director of the National Biosurveillance Integration Center, where he set the vision and strategy of a U.S. government-wide effort to acquire, aggregate, integrate, analyze, interpret and disseminate all-source biosurveillance information from governmental and private sectors for epidemiological analyses and health protection.
+
[One proven method that prevents maggots from becoming flies is public awareness.]
+
